Skip to main content
BioRestorative Therapies, Inc. (FRA:9OF)
Germany flag Germany · Delayed Price · Currency is EUR
0.935
+0.065 (7.47%)
At close: Dec 5, 2025

BioRestorative Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-12.67-8.98-10.42-13.22-44.3-11.27
Upgrade
Depreciation & Amortization
0.210.190.170.120.090.12
Upgrade
Other Amortization
----1.131.28
Upgrade
Stock-Based Compensation
3.052.817.7812.6123.110.69
Upgrade
Other Operating Activities
-1.81-2.28-4.48-5.4416.326.64
Upgrade
Change in Accounts Receivable
0.15-0.17-0-0.010.010.02
Upgrade
Change in Accounts Payable
0.440.290.020.12-0.070.08
Upgrade
Change in Other Net Operating Assets
-0.09-0.10.5-0.090.380.47
Upgrade
Operating Cash Flow
-10.72-8.23-6.43-5.91-3.33-1.96
Upgrade
Capital Expenditures
-0.05-0.11-0.17-0.27-0.03-
Upgrade
Sale (Purchase) of Intangibles
----0.18--
Upgrade
Investment in Securities
8.080.623.42-12.96--
Upgrade
Investing Cash Flow
8.030.513.25-13.4-0.03-
Upgrade
Short-Term Debt Issued
-----1.23
Upgrade
Long-Term Debt Issued
----0.254.29
Upgrade
Total Debt Issued
----0.255.52
Upgrade
Net Debt Issued (Repaid)
----0.255.52
Upgrade
Issuance of Common Stock
2.658.122.35-21.070.01
Upgrade
Other Financing Activities
-0.84-0.74----0.5
Upgrade
Financing Cash Flow
1.817.382.35-21.325.03
Upgrade
Net Cash Flow
-0.89-0.34-0.83-19.3117.963.06
Upgrade
Free Cash Flow
-10.77-8.34-6.6-6.18-3.36-1.96
Upgrade
Free Cash Flow Margin
-2809.20%-2078.94%-4527.61%-5157.20%-7305.58%-2550.99%
Upgrade
Free Cash Flow Per Share
-1.25-1.07-1.56-1.71-2.83-4.98
Upgrade
Levered Free Cash Flow
-6.76-3.11-5.086.155.7-6.31
Upgrade
Unlevered Free Cash Flow
-6.76-3.11-5.086.155.71-6.56
Upgrade
Change in Working Capital
0.50.030.520.010.320.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.